Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001513322 | SCV001720922 | benign | not provided | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506599 | SCV002810815 | likely benign | Developmental and epileptic encephalopathy, 64 | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002564319 | SCV003536646 | likely benign | Inborn genetic diseases | 2021-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001513322 | SCV004164503 | benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | RHOBTB2: BS1, BS2 |
Breakthrough Genomics, |
RCV001513322 | SCV005268915 | benign | not provided | criteria provided, single submitter | not provided |